Patent directory · USPTO A61K / A61P
Patents matching “s1”
59 pharma patents match "s1" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 59 pharmaceutical patents matching "s1" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11191818
Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome
granted -
US 11185575
Subcutaneous administration of ADAMTS13
granted -
US 11124787
ADAMTS13-containing compositions having thrombolytic activity
granted -
US 11028392
Compositions and methods for inhibiting expression of the ALAS1 gene
granted -
US 10968452
Polynucleotide agents targeting aminolevulinic acid synthase-1 (ALAS1) and uses thereof
granted -
US 10953083
Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts
granted -
US 10766892
GLS1 inhibitors for treating disease
granted -
US 10738043
GLS1 inhibitors for treating disease
granted -
US 10669320
Mps1 and KNL1 phosphorylation system
granted -
US 10538765
Organic compositions to treat EPAS1-related diseases
granted -
US 10400239
Compositions and methods for inhibiting expression of the ALAS1 gene
granted -
US 10344025
GLS1 inhibitors for treating disease
granted -
WO 2019016112
COMPOSÉS DE QUINOLÉINE À SUBSTITUTION EN POSITIONS 1, 2, 3 ET 4 UTILISÉS EN TANT QUE MODULATEURS DE S1P
granted -
US 10125128
GLS1 inhibitors for treating disease
granted -
US 10119143
Compositions and methods for inhibiting expression of the ALAS1 gene
granted -
US 10105414
Peptides derived from RS1 which down-regulate glucose absorption after a glucose rich meal and increase insulin sensitivity
granted -
WO 2018083171
COMPOSÉS SPIRO EN TANT QUE MODULATEURS DE S1P
granted -
US 9951017
S1P3 antagonists
granted -
US 9868949
Organic compositions to treat EPAS1-related diseases
granted -
US 9809588
GLS1 inhibitors for treating disease
granted -
US 2017174672
FUSED (HETERO)CYCLIC COMPOUNDS AS S1P MODULATORS
granted -
US 9631193
Compositions and methods for inhibiting expression of the ALAS1 gene
granted -
US 9499588
Flaviviruses expressing the prM, E, and NS1 proteins of other flaviviruses and uses thereof
granted -
US 9133461
Compositions and methods for inhibiting expression of the ALAS1 gene
granted